Literature DB >> 7963557

Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites.

K Hellstrand1, A Asea, C Dahlgren, S Hermodsson.   

Abstract

Monocytes, recovered by centrifugal elutriation, effectively inhibit functions of human NK cells in vitro. Histamine, acting via monocyte H2-type histamine receptors, abrogates the inhibitory signal. The aim of this study was to define the histamine-reversible mechanism by which monocytes inhibit NK cells with special reference to the respiratory burst activity of monocytes. Monocytes recovered from patients with chronic granulomatous disease did not suppress NK cell function, indicating the requirement of intact nicotinamide-adenine dinucleotide phosphate (NAPDH) oxidase activity of monocytes to inhibit NK cells. Furthermore, catalase, a scavenger of hydrogen peroxide (H2O2), was found to potently reverse the monocyte-induced inhibition of NK cell function; on the other hand, superoxide dismutase (a scavenger of superoxide anion), hydroxyl radical scavengers such as mannitol and deferoxamine, the hypochlorous acid scavenger taurin, or the nitric oxide synthetase inhibitor NG-monomethyl-L-arginine (L-NMMA) did not affect the monocyte-derived, suppressive signal. H2O2, at micromolar concentrations, reconstituted the inhibitory effects of monocytes on NK cell function. Histamine had no scavenger activity but effectively suppressed the generation of H2O2 in isolated monocytes. This effect of histamine was transduced by H2-type histamine receptors. We conclude that the histamine-reversible, inhibitory effect of elutriated monocytes on NK cells is dependent on the formation of reactive oxygen metabolites by monocytes and that H2O2 is a pivotal mediator of the suppressive signal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963557

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Histamine reduces susceptibility to natural killer cells via down-regulation of NKG2D ligands on human monocytic leukaemia THP-1 cells.

Authors:  Yasuhiro Nagai; Yukinori Tanaka; Toshinobu Kuroishi; Ryutaro Sato; Yasuo Endo; Shunji Sugawara
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

2.  Histamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidase.

Authors:  Anna Martner; Hanna G Wiktorin; Brianna Lenox; Frida Ewald Sander; Ebru Aydin; Johan Aurelius; Fredrik B Thorén; Anders Ståhlberg; Svante Hermodsson; Kristoffer Hellstrand
Journal:  J Immunol       Date:  2015-04-13       Impact factor: 5.422

Review 3.  Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules.

Authors:  R Kiessling; K Kono; M Petersson; K Wasserman
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Histamine inhibits adhesion molecule expression in human monocytes, induced by advanced glycation end products, during the mixed lymphocyte reaction.

Authors:  J Zhang; H K Takahashi; K Liu; H Wake; R Liu; H Sadamori; H Matsuda; T Yagi; T Yoshino; S Mori; M Nishibori
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 5.  Histamine dihydrochloride: in the management of acute myeloid leukaemia.

Authors:  Lily P H Yang; Caroline M Perry
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

6.  Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells.

Authors:  Johan Aurelius; Anna Martner; Mats Brune; Lars Palmqvist; Markus Hansson; Kristoffer Hellstrand; Fredrik B Thoren
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

7.  Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis.

Authors:  Johan Aurelius; Fredrik B Thorén; Ali A Akhiani; Mats Brune; Lars Palmqvist; Markus Hansson; Kristoffer Hellstrand; Anna Martner
Journal:  Blood       Date:  2012-05-01       Impact factor: 22.113

Review 8.  Alleviating oxidative stress in cancer immunotherapy: a role for histamine?

Authors:  K Hellstrand; M Brune; C Dahlgren; M Hansson; S Hermodsson; P Lindnér; U H Mellqvist; P Naredi
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.064

Review 9.  Mechanisms regulating immune surveillance of cellular stress in cancer.

Authors:  Ruth Seelige; Stephen Searles; Jack D Bui
Journal:  Cell Mol Life Sci       Date:  2017-07-25       Impact factor: 9.261

10.  Role of histamine in natural killer cell-dependent protection against herpes simplex virus type 2 infection in mice.

Authors:  K Hellstrand; A Asea; S Hermodsson
Journal:  Clin Diagn Lab Immunol       Date:  1995-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.